ABSTRACT PURPOSE: Тhe aim of this study was to comparatively evaluate rat experimental colitis resulting from administration of two different doses of trinitrobenzenesulfonic acid (TNBS) dissolved in different volumes of two ethanol concentrations. METHODS: TNBS was applied in the colon by a soft cannula at a depth of about 10 cm from anus. The first group (TNBS20) was treated with 20 mg TNBS dissolved in 0.4 ml of 40% ethanol solution. The second group (TNBS10) was treated with 10 mg TNBS dissolved in 0.25 ml of 50% ethanol solution. Тhe animals were sacrificed 24 hours after the treatment and the colon was examined macroscopically and histopathologically. RESULTS: There were no significant differences regarding the degree of hyperemia, total area of injury and thickening of the colon wall. The higher TNBS dose produced significantly more pronounced shortening of the colon and larger necrotic area. Histopathological evaluation showed similar degree of injuries in the two models. CONCLUSION: The two investigated models of TNBS-induced colitis were comparable according to the overall macroscopic and microscopic criteria for colitis evaluation.
INTRODUCTION

Inflammatory bowel disease (IBD) includes
Crohn's disease and ulcerative colitis -two forms of inflammatory conditions of the colon and small intestine. Both forms usually involve severe diarrhea, pain and weight loss. IBD can be debilitating and sometimes leads to lifethreatening complications. IBD falls into the class of autoimmune diseases, in which the body's own immune system attacks elements of the digestive system. The treatement of the disease is difficult and incomplete and generally immunosuppression is required. The ethiology and pathogenesis are not completely explored to date and have been the object of extensive research recently. Animal models are used in which a chemical agent induces injuries to the colon similar to that of the actual disease. 
MATERIALS AND METHODS
Experimental substances
Trinitrobenzene sulfonic acid (Sigma Aldrich, Germany) was used in the experiment.
Animals and treatment
Male Wistar rats (290-340 g) were used. The animals were housed in plastic cages in a wellventilated room maintained at 22±1°C and on a 12/12 light/dark cycle. They had free access to food and drinking water. All procedures concerning animal treatment and experimentation were conducted in compliance with the National and International laws and policies (EEC Council Directive 86/609).
The experimental animals were divided into two groups of 10 animals each. Rats were fasted for 24 hours. Before TNBS administration, animals were anesthesized with thiopental intraperitoneally to provide a painless procedure. The TNBS solution was applied in the colon through the rectum by a soft cannula inserted at a depth of about 10 cm from anus. The first group (TNBS20) was treated with 20 mg TNBS dissolved in 0.4 ml of 40% ethanol solution. The second group (TNBS10) was treated with 10 mg TNBS dissolved in 0.25 ml of 50% ethanol solution. After TNBS administration, the rats were left in a Trendelenburg position for several minutes to prevent leakage from the anus. The animals were sacrificed 24 hours after the procedure. The colon was excised up to the ileum, washed and opened to be evaluated macroscopically. Tissues were imbedded in 10% neutral buffered formalin solution for histopathological examination.
Macroscopic evaluation
Macroscopic changes were evaluated on the basis of criteria (2) given in Table 1 . 
Microscopic evaluation
Colon tissues were individually fixed in 10% formalin, dehydrated, paraffin embedded, processed and stained with haematoxylin and eosin (H&E).
Statistical analysis
Student's t-test was used to compare variables characterizing the two groups. A level of p < 0.05 was considered significant. GraphPad Prism statistical software was used.
RESULTS
The results from the macroscopic evaluation of the colon tissue of the two groups are presented in Table 2 . A typical macroscopic view of rat colon from group TNBS20 is shown on Figure 1 and from group TNBS10 on Figure 2 . The length of the colon was significantly reduced by TNBS at a dose of 20 mg in comparison with the dose of 10 mg (Figure 3) . The area of injury in TNBS10 group was slightly (but insignificantly) larger than that of TNBS20 group. There was no significant difference between TNBS20 and TNBS10 regarding thickening of the intestinal wall. Hyperemia was insignificantly increased in TNBS10 group compared to TNBS20 group. TNBS at a dose of 20 mg caused a significantly more severe necrosis in comparison to TNBS at dose 10 mg ( Figure  4) . 
Microscopic evaluation
In the damaged areas histopathological evaluation showed diffuse mucosal ulceration involving the submucosa. Extensive and severe edema was observed. Some of the small blood vessels in the submucosa showed fibrinoid necrosis. Severe and diffuse inflammatory infiltration was present reaching the submucosa and involving the muscularis propria and the adipose tissue. The microscopic appearance of the injuries in the two models was similar. An example of the microscopic lesions from group TNBS20 is given in Figure 5 , and one from group TNBS10 is shown in Figure 6 . TNBS is an extremely potent oxidative agent. Oxidative stress has been implicated as a key factor in the pathogenesis of IBD both in human beings and experimental animals. One of the postulated mechanisms, whereby TNBS induces experimental colitis is through increased production of toxic reactive oxygen species (3).
Another important mechanism is the immunological one. When applied intrarectaly, TNBS acts as a chemical hapten to bind proteins in the colon wall and to stimulate cellmediated immunity (1) . Delayed hypersensitivity reactions can be induced because it haptenates proteins with trinitrophenyl groups and renders such proteins immunogenic. This leads to a massive mucosal inflammation characterized by the dense infiltration of T cells and macrophages throughout the entire wall of the large bowel (4, 5) . Delayed-type hypersensitivity is characterized by T cell-driven antigen-specific inflammatory cell infiltration within 12-72 hours after a second encounter with the antigen (6) . Although the exact pathogenesis of IBD still remains unknown, several pathophysiological and histological features of IBD resemble hypersensitivity-like responses in the gastrointestinal tract (7, 8) .
The dose of TNBS capable of inducing adequate inflammation has been reported to be between 50 and 150 mg/kg. Doses above 150 mg/kg are associated with mortality among the experimental animals (3). The doses used in this experiment are in the lowest end of this range. They roughly correspond to doses of 60 and 30 mg/kg, respectively. It was obvious, that both doses worked similarly.
According to literature data, the volume of the inserted TNBS solution into the rectum varies from 0.25 ml to 0.8 ml. Smaller volumes ensure remaining of the agent at the site of application and prevent leakage from the anus. We chose to use a relatively small volume -0.4 ml in the first group and 0.25 ml in the second. Nevertheless, we observed some features of leakage.
Ethanol may not be required for TNBSinduced damage, but this vehicle enhances the biological action of TNBS presumably by acting as a "barrier breaker" (3). Higher ethanol concentrations of TNBS solution are supposed to have stronger damaging effect to the colon wall. This was exactly what we observed in our experiment. Most probably this was the main factor contributing to the absence of significant differences between the two TNBS-induced colitis models.
In conclusion, the results from this experiment demonstrate that TNBS at the two tested doses of 20 mg and 10 mg induced a pronounced experimental colitis. The effect of the smaller dose dissolved in 50% ethanol at a volume of 0.25 ml is almost equivalent to the effect of the higher dose dissolved in 40% ethanol at a volume of 0.40 ml.
